At present, a very big, visionary and topic of discussion news is coming out in the science and health world of the entire Uttar Pradesh and the country, from Bengaluru and New Delhi to Lucknow and Kanpur, related to space science, biotechnology innovation and future medical research possibilities. India is now moving towards using its space capabilities to explore new possibilities in drug and vaccine development. With this goal in mind, the country's scientists, biotech companies and startups are accelerating preparations for research in microgravity i.e. extremely low gravity conditions. Its main objective is to develop such new technologies and medicines that can provide better treatment options for patients in future. During the Tech Summit held in Bengaluru on November 19, the possibilities of manufacturing and testing medicines in space were discussed in depth. According to the report of Channel News Asia, in this conference, researchers, policy makers and entrepreneurs discussed how India's proposed space infrastructure can give new impetus to research in biotechnology and pharma sector. Let us know in detail how research works in microgravity, what Biocon Executive Chairman Kiran Mazumdar-Shaw has said and what plans have come forward for the Indian Space Station. Protein crystals and drug research in microgravity: Why are such experiments difficult on Earth? India is known globally as the 'Pharmacy of the World' as the country supplies affordable medicines and vaccines to the world. Now efforts are being made to link this strong pharmaceutical capability with the space programme. Scientists believe that the microgravity environment present in space can provide an opportunity for such experiments related to the development of medicines, which are relatively difficult to conduct under the influence of Earth's gravity. Actually, the gravitational force of the Earth affects the process of formation of protein crystals, while these crystals play a very important role in understanding the molecular structure of proteins. The reduced impact of gravity in space allows some protein crystals to grow in a more organized manner, which helps scientists study their structure in detail. This scientific understanding can prove useful in the design of new medicines and development of modern treatment methods. Biocon's vision, preparation for Indian Space Station 2035 and initial research India's leading biopharma company Biocon is also looking at possibilities in this emerging field. According to the company's executive chairperson Kiran Mazumdar-Shaw, space technology can be helpful in understanding molecular structures and exploring possibilities related to changes in them, which can open the way to new molecules, intellectual property and better drug development processes. One of the major reasons behind the increasing global interest in space-based biological research is that the International Space Station (ISS) is expected to be retired around the year 2030, due to which various countries and private companies are developing commercial space laboratories keeping in mind the future requirements. India is also preparing to establish its strong presence in this region through the proposed Indian Space Station (Bharatiya Antariksh Station), which is expected to be fully operational by the year 2035. During the 'Space Bio Seminar' organized at the conference, experts brainstormed on how this station can become an important center of international biotechnology and pharmaceutical research in the future. Scientists also believe that for this it is not necessary to wait for the Indian space station to be completely ready, but even before that, experiments related to research in microgravity can be started so that India can get an early lead in this field.